Specifically, EV-mediated delivery of si-HSPD1 capitalizes on both the molecular specificity of RNA interference and the tumor-targeting properties of endogenous vesicle systems 25, establishing a novel theoretical framework for precision intervention in PCa. Here, HSPD1 is linked to neoplasm.